Cargando…

Transcriptional profiles reveal histologic origin and prognosis across 33 The Cancer Genome Atlas tumor types

BACKGROUND: In recent years, with the development of transcriptome sequencing, the molecular characteristics of tumors are gradually revealed. Because of the complexity of tumor transcriptome, there is a need to look for the molecular signatures which can be used to evaluate the tissue origin and ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Hui, Hu, Liang, Tan, Qi, Jia, Jinping, Xie, Ping, Li, Junai, Wang, Minghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643977/
https://www.ncbi.nlm.nih.gov/pubmed/37969389
http://dx.doi.org/10.21037/tcr-23-234
_version_ 1785147185366564864
author Xiao, Hui
Hu, Liang
Tan, Qi
Jia, Jinping
Xie, Ping
Li, Junai
Wang, Minghua
author_facet Xiao, Hui
Hu, Liang
Tan, Qi
Jia, Jinping
Xie, Ping
Li, Junai
Wang, Minghua
author_sort Xiao, Hui
collection PubMed
description BACKGROUND: In recent years, with the development of transcriptome sequencing, the molecular characteristics of tumors are gradually revealed. Because of the complexity of tumor transcriptome, there is a need to look for the molecular signatures which can be used to evaluate the tissue origin and cell stemness of tumors in order to promote the diagnosis and treatment of tumors. METHODS: Tumor tissue-specific gene sets (TTSGs) consisting of 200 genes were selected using RNA expression data of 9,875 patients from 33 tumor types. t-distributed Stochastic Neighbor Embedding (t-SNE) was used for dimensionality reduction and visualization of TTSGs in each tumor type. To evaluate oncogenic dedifferentiation and loss of cell stemness, Euclidean distance from each sample to a human embryo single-cell RNA-seq dataset (GSE36552) of TTSGs was calculated as TTSGs index indicating dissimilarity of tumors and embryo. TTSGs index was evaluated for prognosis in each tumor type. Two published signature indexes, the mRNA signature index (mRNAsi) and CIBERSORT, were compared to assess the correlation between the TTSGs index with cell stemness and immune microenvironment. Finally, the difference of prognosis, immune microenvironment and radiotherapy outcomes were compared between patients with high and low TTSGs index. RESULTS: In this study, all 33 tumor types in The Cancer Genome Atlas (TCGA) were embedded into isolated clusters by t-SNE and confirmed by k-nearest neighbors (kNN) algorithm. Clusters of squamous-cell carcinoma were adjacent to each other revealing similar histologic origin. Basal-like breast cancer was separated from luminal and HER-2-amplified subtypes and closed to squamous-cell carcinoma. TTSGs index was related to overall survival outcomes in cancers derived from liver, thyroid, brain, cervical and kidney. There was a positive correlation between mRNAsi and TTSGs index in pan-kidney and pan-neuronal cancers. Furthermore, cell fractions of M2 macrophages and total leukocytes increased in the group with higher TTSGs index. Patients with higher TTSGs index had longer overall survival time and less radiation therapy resistance compared to patients with lower TTSGs index. CONCLUSIONS: The signature of TTSGs is related to tumor expression features that distinguish tumors of different histologic origin using t-SNE. The signature also relates to prognosis of certain kinds of tumors.
format Online
Article
Text
id pubmed-10643977
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-106439772023-11-15 Transcriptional profiles reveal histologic origin and prognosis across 33 The Cancer Genome Atlas tumor types Xiao, Hui Hu, Liang Tan, Qi Jia, Jinping Xie, Ping Li, Junai Wang, Minghua Transl Cancer Res Original Article BACKGROUND: In recent years, with the development of transcriptome sequencing, the molecular characteristics of tumors are gradually revealed. Because of the complexity of tumor transcriptome, there is a need to look for the molecular signatures which can be used to evaluate the tissue origin and cell stemness of tumors in order to promote the diagnosis and treatment of tumors. METHODS: Tumor tissue-specific gene sets (TTSGs) consisting of 200 genes were selected using RNA expression data of 9,875 patients from 33 tumor types. t-distributed Stochastic Neighbor Embedding (t-SNE) was used for dimensionality reduction and visualization of TTSGs in each tumor type. To evaluate oncogenic dedifferentiation and loss of cell stemness, Euclidean distance from each sample to a human embryo single-cell RNA-seq dataset (GSE36552) of TTSGs was calculated as TTSGs index indicating dissimilarity of tumors and embryo. TTSGs index was evaluated for prognosis in each tumor type. Two published signature indexes, the mRNA signature index (mRNAsi) and CIBERSORT, were compared to assess the correlation between the TTSGs index with cell stemness and immune microenvironment. Finally, the difference of prognosis, immune microenvironment and radiotherapy outcomes were compared between patients with high and low TTSGs index. RESULTS: In this study, all 33 tumor types in The Cancer Genome Atlas (TCGA) were embedded into isolated clusters by t-SNE and confirmed by k-nearest neighbors (kNN) algorithm. Clusters of squamous-cell carcinoma were adjacent to each other revealing similar histologic origin. Basal-like breast cancer was separated from luminal and HER-2-amplified subtypes and closed to squamous-cell carcinoma. TTSGs index was related to overall survival outcomes in cancers derived from liver, thyroid, brain, cervical and kidney. There was a positive correlation between mRNAsi and TTSGs index in pan-kidney and pan-neuronal cancers. Furthermore, cell fractions of M2 macrophages and total leukocytes increased in the group with higher TTSGs index. Patients with higher TTSGs index had longer overall survival time and less radiation therapy resistance compared to patients with lower TTSGs index. CONCLUSIONS: The signature of TTSGs is related to tumor expression features that distinguish tumors of different histologic origin using t-SNE. The signature also relates to prognosis of certain kinds of tumors. AME Publishing Company 2023-09-20 2023-10-31 /pmc/articles/PMC10643977/ /pubmed/37969389 http://dx.doi.org/10.21037/tcr-23-234 Text en 2023 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Xiao, Hui
Hu, Liang
Tan, Qi
Jia, Jinping
Xie, Ping
Li, Junai
Wang, Minghua
Transcriptional profiles reveal histologic origin and prognosis across 33 The Cancer Genome Atlas tumor types
title Transcriptional profiles reveal histologic origin and prognosis across 33 The Cancer Genome Atlas tumor types
title_full Transcriptional profiles reveal histologic origin and prognosis across 33 The Cancer Genome Atlas tumor types
title_fullStr Transcriptional profiles reveal histologic origin and prognosis across 33 The Cancer Genome Atlas tumor types
title_full_unstemmed Transcriptional profiles reveal histologic origin and prognosis across 33 The Cancer Genome Atlas tumor types
title_short Transcriptional profiles reveal histologic origin and prognosis across 33 The Cancer Genome Atlas tumor types
title_sort transcriptional profiles reveal histologic origin and prognosis across 33 the cancer genome atlas tumor types
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643977/
https://www.ncbi.nlm.nih.gov/pubmed/37969389
http://dx.doi.org/10.21037/tcr-23-234
work_keys_str_mv AT xiaohui transcriptionalprofilesrevealhistologicoriginandprognosisacross33thecancergenomeatlastumortypes
AT huliang transcriptionalprofilesrevealhistologicoriginandprognosisacross33thecancergenomeatlastumortypes
AT tanqi transcriptionalprofilesrevealhistologicoriginandprognosisacross33thecancergenomeatlastumortypes
AT jiajinping transcriptionalprofilesrevealhistologicoriginandprognosisacross33thecancergenomeatlastumortypes
AT xieping transcriptionalprofilesrevealhistologicoriginandprognosisacross33thecancergenomeatlastumortypes
AT lijunai transcriptionalprofilesrevealhistologicoriginandprognosisacross33thecancergenomeatlastumortypes
AT wangminghua transcriptionalprofilesrevealhistologicoriginandprognosisacross33thecancergenomeatlastumortypes